<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>风云药谈 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-23T20:22:56+08:00</updated>
  <subtitle>分享、交流、学习</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>500大目录进度表，国采69.省采174.未采158</title>
    <updated>2020-11-23T18:44:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/qzI5Q6-PqkFxcFetQheQxg</id>
    <link href="https://mp.weixin.qq.com/s/qzI5Q6-PqkFxcFetQheQxg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>符合第四批集采产品仅有60个，必须清楚！</title>
    <updated>2020-11-22T11:30:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/mxTt1RvWtibUCSdWbZuGvA</id>
    <link href="https://mp.weixin.qq.com/s/mxTt1RvWtibUCSdWbZuGvA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【新方法】加速药物上市之“KeyPoint”——临床试验创新设计</title>
    <updated>2020-11-22T11:30:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/UY3l9QPh1HCvobVVmp_UKw</id>
    <link href="https://mp.weixin.qq.com/s/UY3l9QPh1HCvobVVmp_UKw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>四川、重庆、陕西联盟“带量采”开启，500大目录已过三分之二！</title>
    <updated>2020-11-21T18:18:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-21:/s/Z5uUzSrpIDgGnqFdOnVQVQ</id>
    <link href="https://mp.weixin.qq.com/s/Z5uUzSrpIDgGnqFdOnVQVQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“魔针”  中国面世了！！！</title>
    <updated>2020-11-21T18:18:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-21:/s/MBImNciW9M1V_ZFtr3x34A</id>
    <link href="https://mp.weixin.qq.com/s/MBImNciW9M1V_ZFtr3x34A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>江苏“带量采”产品猜测，附TOP200名单。</title>
    <updated>2020-11-20T17:58:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/yXy9uMJJs1l3c28nM1O3Fw</id>
    <link href="https://mp.weixin.qq.com/s/yXy9uMJJs1l3c28nM1O3Fw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【新方法】加速药物上市之“KeyPoint”——临床试验创新设计</title>
    <updated>2020-11-20T17:58:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/Qbb6q65FtWpaOp7JlMlaEg</id>
    <link href="https://mp.weixin.qq.com/s/Qbb6q65FtWpaOp7JlMlaEg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>从97国看，想进2020版医保价格要降多少？</title>
    <updated>2020-11-18T19:50:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/nBZ_z5ixBqEKCkiKfeHfpg</id>
    <link href="https://mp.weixin.qq.com/s/nBZ_z5ixBqEKCkiKfeHfpg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>官方重磅 | 80+行业领军学者齐聚，12月千人药物创新盛会</title>
    <updated>2020-11-18T19:50:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/JvfeWxfk-EkVYBJIgjgCbg</id>
    <link href="https://mp.weixin.qq.com/s/JvfeWxfk-EkVYBJIgjgCbg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>最新基药调整的五个方向六条意见.收藏。</title>
    <updated>2020-11-17T17:41:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/Cp1VrfqG1JHezBVnLOepeA</id>
    <link href="https://mp.weixin.qq.com/s/Cp1VrfqG1JHezBVnLOepeA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>官方重磅 | 80+行业领军学者齐聚，12月千人药物创新盛会</title>
    <updated>2020-11-17T17:41:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/9730DNw_H8YHr9HMO4g8Zw</id>
    <link href="https://mp.weixin.qq.com/s/9730DNw_H8YHr9HMO4g8Zw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>4+7扩围如此续标，后续过评产品“凉凉”？</title>
    <updated>2020-11-16T16:24:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/zPawvXiJjFGvTZ074FORlA</id>
    <link href="https://mp.weixin.qq.com/s/zPawvXiJjFGvTZ074FORlA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“4+7扩围标”即将到期，一年到期如何续命？</title>
    <updated>2020-11-15T10:46:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/jvyYYu337nV7jWFFcof6Vg</id>
    <link href="https://mp.weixin.qq.com/s/jvyYYu337nV7jWFFcof6Vg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>山东公布“带量大数据”，大湖北搞“抗生素带量采”</title>
    <updated>2020-11-13T19:01:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/nTSiqgEmaTIaOC0dg8gZyg</id>
    <link href="https://mp.weixin.qq.com/s/nTSiqgEmaTIaOC0dg8gZyg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“报量半个亿”的浙江，大招频出，能否成为全国标杆？</title>
    <updated>2020-11-12T19:26:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/VB37wR591VKce7ahqhxzgA</id>
    <link href="https://mp.weixin.qq.com/s/VB37wR591VKce7ahqhxzgA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>